Endogenous inhibitors of angiogenesisNYBERG, Pia; LIANG XIE; KALLURI, Raghu et al.Cancer research (Baltimore). 2005, Vol 65, Num 10, pp 3967-3979, issn 0008-5472, 13 p.Article

Nouveaux antiangiogéniques: état de la recherche : Antiangiogéniques et cancer colorectal métastatique = Update on novel antiangiogenic compoundsJOUINOT, Anne; DREYER, Chantal; BOUATTOUR, Mohamed et al.Cancéro digest. 2010, Vol 2, Num 3, pp 199-204, issn 1953-5171, 6 p.Article

Combining Antiangiogenics to Overcome Resistance: Rationale and Clinical ExperienceMORENO GARCIA, Victor; BASU, Bristi; MOLIFE, L. Rhoda et al.Clinical cancer research (Print). 2012, Vol 18, Num 14, pp 3750-3761, issn 1078-0432, 12 p.Article

Evaluation of the Antiangiogenic Potential of AQ4NO'ROURKE, Martin; WARD, Claire; WORTHINGTON, Jenny et al.Clinical cancer research. 2008, Vol 14, Num 5, pp 1502-1509, issn 1078-0432, 8 p.Article

Inhibitors of Angiogenesis: New Hopes for Oncologists, New Challenges for AnesthesiologistsLIBERT, Nicolas; TOURTIER, Jean-Pierre; VEDRINE, Lionel et al.Anesthesiology (Philadelphia). 2010, Vol 113, Num 3, pp 704-712, issn 0003-3022, 9 p.Article

Angiogenesis inhibitors: Current & future directionsMOUSA, Shaker A; MOUSA, Ahmed S.Current pharmaceutical design. 2004, Vol 10, Num 1, pp 1-9, issn 1381-6128, 9 p.Article

Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic TherapyBAGLEY, Rebecca G; YI REN; TEICHER, Beverly A et al.Clinical cancer research (Print). 2011, Vol 17, Num 5, pp 976-988, issn 1078-0432, 13 p.Article

The Angiogenesis Inhibitor Thrombospondin-1 Inhibits Acute Cutaneous Hypersensitivity ReactionsVELASCO, Paula; HUEGEL, Rainer; BRASCH, Jochen et al.Journal of investigative dermatology. 2009, Vol 129, Num 8, pp 2022-2030, issn 0022-202X, 9 p.Article

Antiangiogenic potential of the mammalian target of rapamycin inhibitor temsirolimusDEL BUFALO, Donatella; CIUFFREDA, Ludovica; TRISCIUOGLIO, Daniela et al.Cancer research (Baltimore). 2006, Vol 66, Num 11, pp 5549-5554, issn 0008-5472, 6 p.Article

AfliberceptCIOMBOR, Kristen K; BERLIN, Jordan; CHAN, Emily et al.Clinical cancer research (Print). 2013, Vol 19, Num 8, pp 1920-1925, issn 1078-0432, 6 p.Article

Thrombospondin-1: Multiple Paths to InflammationLOPEZ-DEE, Zenaida; PIDCOCK, Kenneth; GUTIERREZ, Linda S et al.Mediators of inflammation. 2011, Vol 2011, Num 2, issn 0962-9351, 296069.1-296069.10Article

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesisBOCK, Felix; ONDERKA, Jasmine; DIETRICH, Tina et al.Investigative ophthalmology & visual science. 2007, Vol 48, Num 6, pp 2545-2552, issn 0146-0404, 8 p.Article

Antiangiogenic properties of gold nanoparticlesMUKHERJEE, Priyabrata; BHATTACHARYA, Resham; PING WANG et al.Clinical cancer research. 2005, Vol 11, Num 9, pp 3530-3534, issn 1078-0432, 5 p.Article

Semaphorin-3F is an inhibitor of tumor angiogenesisKESSLER, Ofra; SHRAGA-HELED, Niva; LANGE, Tali et al.Cancer research (Baltimore). 2004, Vol 64, Num 3, pp 1008-1015, issn 0008-5472, 8 p.Article

Anti-angiogenic therapy: Rationale, challenges and clinical studiesLONGO, R; SARMIENTO, R; FANELLI, M et al.Angiogenesis (London). 2002, Vol 5, Num 4, pp 237-256, issn 0969-6970, 20 p.Article

Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment BreaksEBOS, John M. L; PILI, Roberto.Clinical cancer research (Print). 2012, Vol 18, Num 14, pp 3719-3721, issn 1078-0432, 3 p.Article

Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuliCHATTERJEE, Madhumita; ZHANGSEN HUANG; WEI ZHANG et al.Blood. 2011, Vol 117, Num 14, pp 3907-3911, issn 0006-4971, 5 p.Article

Resistance and Escape From Antiangiogenesis Therapy: Clinical Implications and Future StrategiesBOTTSFORD-MILLER, Justin N; COLEMAN, Robert L; SOOD, Anil K et al.Journal of clinical oncology. 2012, Vol 30, Num 32, pp 4026-4034, issn 0732-183X, 9 p.Article

Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitutionUDAGAWA, Taturo; BIRSNER, Amy E; WOOD, Mark et al.Cancer research (Baltimore). 2007, Vol 67, Num 5, pp 2040-2045, issn 0008-5472, 6 p.Article

Antiangiogenesis Enhances Intratumoral Drug RetentionJIE MA; CHEN, Chong-Sheng; BLUTE, Todd et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 7, pp 2675-2685, issn 0008-5472, 11 p.Article

Histidine-Rich Glycoprotein Modulates the Anti-Angiogenic Effects of VasculostatinKLENOTIC, Philip A; PING HUANG; PALOMO, Juan et al.The American journal of pathology. 2010, Vol 176, Num 4, pp 2039-2050, issn 0002-9440, 12 p.Article

Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF₁₆₅ binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complexSTARZEC, Anna; LADAM, Patrick; VASSY, Roger et al.Peptides (New York, NY. 1980). 2007, Vol 28, Num 12, pp 2397-2402, issn 0196-9781, 6 p.Article

Interstitial Granulomatous Drug Reaction to SorafenibMARTINEZ-MORAN, Cristina; NAJERA, Laura; RUIZ-CASADO, Ana I et al.Archives of dermatology (1960). 2011, Vol 147, Num 9, pp 1118-1119, issn 0003-987X, 2 p.Article

Antiangiogenic Effects of Indole-3-Carbinol and 3,3'-Diindolylmethane Are Associated with Their Differential Regulation of ERK1/2 and Akt in Tube-Forming HUVECKUNIMASA, Kazuhiro; KOBAYASHI, Tomomi; KAJI, Kazuhiko et al.The Journal of nutrition. 2010, Vol 140, Num 1, pp 1-6, issn 0022-3166, 6 p.Article

Twin-to-twin transfusion syndrome : an antiangiogenic state?PEDRO KUSANOVIC, Juan; ROMERO, Roberto; THAN, Nandor G et al.American journal of obstetrics and gynecology. 2008, Vol 198, Num 4, pp 382-384, issn 0002-9378, 3 p.Article